Starting January the 1st the nations largest pharmacy benefit manager, Express Script, chooses a more cost effective hepatitis C medication and will no longer cover Sovaldi, the uber expensive Hepatitis C drug. The company will go for Viekira Park, a rival medication, which has been approved by the Food and Drug Administration on Friday. Even though Sovaldi, which was approved in December 2013, … [Read more...]
New drug boasts to cure Hepatitis C with 95 percent success rate
American and German researchers have created an experimental drug, ABT-450, that they boast can treat Hepatitis C with 95 percent success rate. The researchers have claimed that the drug was found effective in patients who failed to respond to earlier treatments. The drug has been developed by AbbVie, which has funded the study. The patients were found responding well to the experimental … [Read more...]
New Hep C drug Sovaldi comes with $1000 price tag
Now you have to pay $1000 to buy one tablet of a new Hepatitis C drug named Sovaldi. According to the manufacturer Gilead Sciences, it has put the price tag of its new Hepatitis C drug $1000, which means the number of pills required for a full course of treatment will set you back $84,000. Gilead Sciences boasts that its new drug Sovaldi is going to defeat the Hep C as clinical trial shows … [Read more...]
